nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxetine—panic disorder—Citalopram—alcohol dependence	0.331	1	CpDpCtD
Fluoxetine—SLC6A4—alcohol dependence	0.13	0.565	CbGaD
Fluoxetine—HTR2A—alcohol dependence	0.1	0.435	CbGaD
Fluoxetine—SLC6A4—Citalopram—alcohol dependence	0.0427	0.164	CbGbCtD
Fluoxetine—HTR2C—Citalopram—alcohol dependence	0.0357	0.137	CbGbCtD
Fluoxetine—SLC6A2—Citalopram—alcohol dependence	0.0357	0.137	CbGbCtD
Fluoxetine—CYP3A5—Disulfiram—alcohol dependence	0.0245	0.0943	CbGbCtD
Fluoxetine—CYP2B6—Citalopram—alcohol dependence	0.0222	0.0853	CbGbCtD
Fluoxetine—ABCB1—Naltrexone—alcohol dependence	0.0171	0.066	CbGbCtD
Fluoxetine—CYP2C9—Disulfiram—alcohol dependence	0.0164	0.0632	CbGbCtD
Fluoxetine—CYP2C19—Citalopram—alcohol dependence	0.0141	0.0542	CbGbCtD
Fluoxetine—CYP1A2—Citalopram—alcohol dependence	0.013	0.05	CbGbCtD
Fluoxetine—ABCB1—Citalopram—alcohol dependence	0.0114	0.0437	CbGbCtD
Fluoxetine—CYP2D6—Citalopram—alcohol dependence	0.0107	0.0412	CbGbCtD
Fluoxetine—CYP3A4—Disulfiram—alcohol dependence	0.00955	0.0368	CbGbCtD
Fluoxetine—CYP3A4—Citalopram—alcohol dependence	0.00681	0.0262	CbGbCtD
Fluoxetine—ORM1—bile—alcohol dependence	0.00232	0.0833	CbGeAlD
Fluoxetine—SLC6A2—locus ceruleus—alcohol dependence	0.00219	0.0785	CbGeAlD
Fluoxetine—ORM1—saliva—alcohol dependence	0.00152	0.0543	CbGeAlD
Fluoxetine—HTR2A—locus ceruleus—alcohol dependence	0.00132	0.0472	CbGeAlD
Fluoxetine—SLC6A2—autonomic nervous system—alcohol dependence	0.00116	0.0417	CbGeAlD
Fluoxetine—HTR2A—cerebellar cortex—alcohol dependence	0.00107	0.0385	CbGeAlD
Fluoxetine—HTR2A—pons—alcohol dependence	0.000758	0.0272	CbGeAlD
Fluoxetine—HTR2A—autonomic nervous system—alcohol dependence	0.000699	0.0251	CbGeAlD
Fluoxetine—SLC6A2—nerve—alcohol dependence	0.000654	0.0235	CbGeAlD
Fluoxetine—HTR2A—nerve—alcohol dependence	0.000393	0.0141	CbGeAlD
Fluoxetine—Duloxetine—SLC6A3—alcohol dependence	0.000367	0.206	CrCbGaD
Fluoxetine—HTR2C—brainstem—alcohol dependence	0.000337	0.0121	CbGeAlD
Fluoxetine—HTR2C—forebrain—alcohol dependence	0.000325	0.0116	CbGeAlD
Fluoxetine—SLC6A4—brainstem—alcohol dependence	0.000319	0.0114	CbGeAlD
Fluoxetine—SLC6A4—forebrain—alcohol dependence	0.000308	0.011	CbGeAlD
Fluoxetine—SIGMAR1—adrenal cortex—alcohol dependence	0.000283	0.0102	CbGeAlD
Fluoxetine—SLC6A2—brainstem—alcohol dependence	0.000281	0.0101	CbGeAlD
Fluoxetine—Duloxetine—SLC6A4—alcohol dependence	0.000274	0.154	CrCbGaD
Fluoxetine—SLC6A2—forebrain—alcohol dependence	0.000271	0.00972	CbGeAlD
Fluoxetine—SIGMAR1—pancreas—alcohol dependence	0.000251	0.00901	CbGeAlD
Fluoxetine—ORM1—blood—alcohol dependence	0.000242	0.00866	CbGeAlD
Fluoxetine—SLC6A4—digestive system—alcohol dependence	0.000216	0.00775	CbGeAlD
Fluoxetine—HTR2C—midbrain—alcohol dependence	0.000214	0.00769	CbGeAlD
Fluoxetine—Atomoxetine—HTR1B—alcohol dependence	0.000213	0.119	CrCbGaD
Fluoxetine—Duloxetine—HTR2A—alcohol dependence	0.000211	0.118	CrCbGaD
Fluoxetine—ORM1—endocrine gland—alcohol dependence	0.00021	0.00751	CbGeAlD
Fluoxetine—SLC6A2—gonad—alcohol dependence	0.000208	0.00746	CbGeAlD
Fluoxetine—SLC6A4—blood—alcohol dependence	0.000206	0.00738	CbGeAlD
Fluoxetine—SIGMAR1—blood—alcohol dependence	0.000204	0.00733	CbGeAlD
Fluoxetine—SLC6A4—midbrain—alcohol dependence	0.000203	0.00729	CbGeAlD
Fluoxetine—SIGMAR1—midbrain—alcohol dependence	0.000202	0.00724	CbGeAlD
Fluoxetine—ORM1—nervous system—alcohol dependence	0.000196	0.00703	CbGeAlD
Fluoxetine—Atomoxetine—SLC6A3—alcohol dependence	0.000192	0.108	CrCbGaD
Fluoxetine—ORM1—liver—alcohol dependence	0.000189	0.00678	CbGeAlD
Fluoxetine—ORM1—central nervous system—alcohol dependence	0.000189	0.00677	CbGeAlD
Fluoxetine—CYP2B6—adrenal cortex—alcohol dependence	0.000185	0.00664	CbGeAlD
Fluoxetine—CYP2C19—digestive system—alcohol dependence	0.000179	0.00642	CbGeAlD
Fluoxetine—SLC6A4—endocrine gland—alcohol dependence	0.000179	0.0064	CbGeAlD
Fluoxetine—HTR2C—nervous system—alcohol dependence	0.000176	0.00632	CbGeAlD
Fluoxetine—ALB—testis—alcohol dependence	0.000175	0.00628	CbGeAlD
Fluoxetine—CYP2C19—blood—alcohol dependence	0.000171	0.00612	CbGeAlD
Fluoxetine—HTR2C—central nervous system—alcohol dependence	0.00017	0.00609	CbGeAlD
Fluoxetine—SIGMAR1—testis—alcohol dependence	0.000169	0.00606	CbGeAlD
Fluoxetine—CYP2B6—cardiovascular system—alcohol dependence	0.000169	0.00606	CbGeAlD
Fluoxetine—HTR2A—brainstem—alcohol dependence	0.000169	0.00605	CbGeAlD
Fluoxetine—Orphenadrine—CHRM2—alcohol dependence	0.000168	0.0945	CrCbGaD
Fluoxetine—CYP2C9—cardiovascular system—alcohol dependence	0.000167	0.006	CbGeAlD
Fluoxetine—SLC6A4—nervous system—alcohol dependence	0.000167	0.00599	CbGeAlD
Fluoxetine—ALB—liver—alcohol dependence	0.000166	0.00594	CbGeAlD
Fluoxetine—CYP3A5—pancreas—alcohol dependence	0.000165	0.00592	CbGeAlD
Fluoxetine—HTR2A—forebrain—alcohol dependence	0.000163	0.00584	CbGeAlD
Fluoxetine—SLC6A4—central nervous system—alcohol dependence	0.000161	0.00577	CbGeAlD
Fluoxetine—SIGMAR1—liver—alcohol dependence	0.00016	0.00573	CbGeAlD
Fluoxetine—SLC6A2—endocrine gland—alcohol dependence	0.000157	0.00564	CbGeAlD
Fluoxetine—SIGMAR1—cerebellum—alcohol dependence	0.000156	0.0056	CbGeAlD
Fluoxetine—CYP2D6—brainstem—alcohol dependence	0.000154	0.00551	CbGeAlD
Fluoxetine—CYP2B6—gonad—alcohol dependence	0.000153	0.0055	CbGeAlD
Fluoxetine—SLC6A2—testis—alcohol dependence	0.00015	0.00538	CbGeAlD
Fluoxetine—CYP2D6—forebrain—alcohol dependence	0.000148	0.00532	CbGeAlD
Fluoxetine—CYP2C19—endocrine gland—alcohol dependence	0.000148	0.00531	CbGeAlD
Fluoxetine—SLC6A2—nervous system—alcohol dependence	0.000147	0.00528	CbGeAlD
Fluoxetine—CYP1A2—digestive system—alcohol dependence	0.000146	0.00524	CbGeAlD
Fluoxetine—Atomoxetine—SLC6A4—alcohol dependence	0.000144	0.0805	CrCbGaD
Fluoxetine—SLC6A2—central nervous system—alcohol dependence	0.000142	0.00508	CbGeAlD
Fluoxetine—CYP3A5—digestive system—alcohol dependence	0.000141	0.00506	CbGeAlD
Fluoxetine—CYP2B6—digestive system—alcohol dependence	0.00014	0.00503	CbGeAlD
Fluoxetine—CYP1A2—blood—alcohol dependence	0.000139	0.005	CbGeAlD
Fluoxetine—CYP2C9—digestive system—alcohol dependence	0.000139	0.00498	CbGeAlD
Fluoxetine—HTR2A—cardiovascular system—alcohol dependence	0.000138	0.00494	CbGeAlD
Fluoxetine—HTR2C—brain—alcohol dependence	0.000135	0.00483	CbGeAlD
Fluoxetine—CYP3A5—blood—alcohol dependence	0.000134	0.00482	CbGeAlD
Fluoxetine—CYP2B6—blood—alcohol dependence	0.000134	0.00479	CbGeAlD
Fluoxetine—CYP2C19—liver—alcohol dependence	0.000133	0.00478	CbGeAlD
Fluoxetine—CYP2C9—blood—alcohol dependence	0.000132	0.00474	CbGeAlD
Fluoxetine—ALB—brain—alcohol dependence	0.000131	0.00471	CbGeAlD
Fluoxetine—SLC6A4—brain—alcohol dependence	0.000128	0.00458	CbGeAlD
Fluoxetine—SIGMAR1—brain—alcohol dependence	0.000127	0.00455	CbGeAlD
Fluoxetine—HTR2A—gonad—alcohol dependence	0.000125	0.00448	CbGeAlD
Fluoxetine—CYP1A2—endocrine gland—alcohol dependence	0.000121	0.00433	CbGeAlD
Fluoxetine—CYP3A5—endocrine gland—alcohol dependence	0.000117	0.00418	CbGeAlD
Fluoxetine—CYP2B6—endocrine gland—alcohol dependence	0.000116	0.00415	CbGeAlD
Fluoxetine—CYP2C9—endocrine gland—alcohol dependence	0.000115	0.00411	CbGeAlD
Fluoxetine—HTR2A—digestive system—alcohol dependence	0.000114	0.0041	CbGeAlD
Fluoxetine—SLC6A2—brain—alcohol dependence	0.000112	0.00403	CbGeAlD
Fluoxetine—CYP2B6—testis—alcohol dependence	0.00011	0.00396	CbGeAlD
Fluoxetine—Atomoxetine—HTR2A—alcohol dependence	0.00011	0.0619	CrCbGaD
Fluoxetine—CYP1A2—liver—alcohol dependence	0.000109	0.00391	CbGeAlD
Fluoxetine—HTR2A—blood—alcohol dependence	0.000109	0.00391	CbGeAlD
Fluoxetine—CYP2B6—nervous system—alcohol dependence	0.000108	0.00389	CbGeAlD
Fluoxetine—HTR2A—midbrain—alcohol dependence	0.000108	0.00386	CbGeAlD
Fluoxetine—ABCB1—forebrain—alcohol dependence	0.000107	0.00383	CbGeAlD
Fluoxetine—CYP3A4—digestive system—alcohol dependence	0.000106	0.0038	CbGeAlD
Fluoxetine—CYP3A5—liver—alcohol dependence	0.000105	0.00377	CbGeAlD
Fluoxetine—Orphenadrine—CYP2E1—alcohol dependence	0.000105	0.0589	CrCbGaD
Fluoxetine—CYP2B6—liver—alcohol dependence	0.000104	0.00375	CbGeAlD
Fluoxetine—CYP2B6—central nervous system—alcohol dependence	0.000104	0.00374	CbGeAlD
Fluoxetine—CYP2D6—digestive system—alcohol dependence	0.000104	0.00374	CbGeAlD
Fluoxetine—CYP2C9—liver—alcohol dependence	0.000103	0.00371	CbGeAlD
Fluoxetine—CYP3A4—blood—alcohol dependence	0.000101	0.00362	CbGeAlD
Fluoxetine—CYP2D6—blood—alcohol dependence	9.93e-05	0.00356	CbGeAlD
Fluoxetine—ABCB1—adrenal cortex—alcohol dependence	9.89e-05	0.00355	CbGeAlD
Fluoxetine—HTR2A—endocrine gland—alcohol dependence	9.45e-05	0.00339	CbGeAlD
Fluoxetine—ABCB1—cardiovascular system—alcohol dependence	9.03e-05	0.00324	CbGeAlD
Fluoxetine—HTR2A—testis—alcohol dependence	9.01e-05	0.00323	CbGeAlD
Fluoxetine—HTR2A—nervous system—alcohol dependence	8.84e-05	0.00317	CbGeAlD
Fluoxetine—ABCB1—pancreas—alcohol dependence	8.78e-05	0.00315	CbGeAlD
Fluoxetine—CYP3A4—endocrine gland—alcohol dependence	8.75e-05	0.00314	CbGeAlD
Fluoxetine—CYP2D6—endocrine gland—alcohol dependence	8.61e-05	0.00309	CbGeAlD
Fluoxetine—HTR2A—liver—alcohol dependence	8.52e-05	0.00305	CbGeAlD
Fluoxetine—HTR2A—central nervous system—alcohol dependence	8.52e-05	0.00305	CbGeAlD
Fluoxetine—HTR2A—cerebellum—alcohol dependence	8.32e-05	0.00298	CbGeAlD
Fluoxetine—CYP2B6—brain—alcohol dependence	8.29e-05	0.00297	CbGeAlD
Fluoxetine—CYP2D6—testis—alcohol dependence	8.21e-05	0.00294	CbGeAlD
Fluoxetine—ABCB1—gonad—alcohol dependence	8.19e-05	0.00294	CbGeAlD
Fluoxetine—CYP3A4—nervous system—alcohol dependence	8.19e-05	0.00294	CbGeAlD
Fluoxetine—CYP2D6—nervous system—alcohol dependence	8.06e-05	0.00289	CbGeAlD
Fluoxetine—CYP3A4—liver—alcohol dependence	7.89e-05	0.00283	CbGeAlD
Fluoxetine—CYP3A4—central nervous system—alcohol dependence	7.88e-05	0.00283	CbGeAlD
Fluoxetine—Chills—Naltrexone—alcohol dependence	7.82e-05	0.000726	CcSEcCtD
Fluoxetine—Psychotic disorder—Citalopram—alcohol dependence	7.8e-05	0.000724	CcSEcCtD
Fluoxetine—Nervousness—Acamprosate—alcohol dependence	7.79e-05	0.000723	CcSEcCtD
Fluoxetine—CYP2D6—liver—alcohol dependence	7.76e-05	0.00278	CbGeAlD
Fluoxetine—Back pain—Acamprosate—alcohol dependence	7.76e-05	0.00072	CcSEcCtD
Fluoxetine—CYP2D6—central nervous system—alcohol dependence	7.76e-05	0.00278	CbGeAlD
Fluoxetine—Muscle spasms—Acamprosate—alcohol dependence	7.71e-05	0.000716	CcSEcCtD
Fluoxetine—Face oedema—Citalopram—alcohol dependence	7.71e-05	0.000716	CcSEcCtD
Fluoxetine—Alopecia—Naltrexone—alcohol dependence	7.71e-05	0.000715	CcSEcCtD
Fluoxetine—Mental disorder—Naltrexone—alcohol dependence	7.64e-05	0.000709	CcSEcCtD
Fluoxetine—Irritability—Citalopram—alcohol dependence	7.62e-05	0.000708	CcSEcCtD
Fluoxetine—Urinary retention—Citalopram—alcohol dependence	7.59e-05	0.000705	CcSEcCtD
Fluoxetine—Cardiac arrest—Citalopram—alcohol dependence	7.59e-05	0.000705	CcSEcCtD
Fluoxetine—Malnutrition—Naltrexone—alcohol dependence	7.59e-05	0.000705	CcSEcCtD
Fluoxetine—CYP2D6—cerebellum—alcohol dependence	7.58e-05	0.00272	CbGeAlD
Fluoxetine—Mood swings—Citalopram—alcohol dependence	7.57e-05	0.000702	CcSEcCtD
Fluoxetine—Tremor—Acamprosate—alcohol dependence	7.52e-05	0.000698	CcSEcCtD
Fluoxetine—Ataxia—Citalopram—alcohol dependence	7.51e-05	0.000697	CcSEcCtD
Fluoxetine—ABCB1—digestive system—alcohol dependence	7.49e-05	0.00269	CbGeAlD
Fluoxetine—Flatulence—Naltrexone—alcohol dependence	7.48e-05	0.000694	CcSEcCtD
Fluoxetine—Tension—Naltrexone—alcohol dependence	7.45e-05	0.000691	CcSEcCtD
Fluoxetine—Ill-defined disorder—Acamprosate—alcohol dependence	7.44e-05	0.000691	CcSEcCtD
Fluoxetine—Dysgeusia—Naltrexone—alcohol dependence	7.43e-05	0.00069	CcSEcCtD
Fluoxetine—Dehydration—Citalopram—alcohol dependence	7.43e-05	0.000689	CcSEcCtD
Fluoxetine—Anaemia—Acamprosate—alcohol dependence	7.42e-05	0.000688	CcSEcCtD
Fluoxetine—Liver function test abnormal—Citalopram—alcohol dependence	7.37e-05	0.000684	CcSEcCtD
Fluoxetine—Agitation—Acamprosate—alcohol dependence	7.37e-05	0.000684	CcSEcCtD
Fluoxetine—Nervousness—Naltrexone—alcohol dependence	7.37e-05	0.000684	CcSEcCtD
Fluoxetine—Back pain—Naltrexone—alcohol dependence	7.34e-05	0.000682	CcSEcCtD
Fluoxetine—Angioedema—Acamprosate—alcohol dependence	7.33e-05	0.000681	CcSEcCtD
Fluoxetine—Dry skin—Citalopram—alcohol dependence	7.32e-05	0.00068	CcSEcCtD
Fluoxetine—Muscle spasms—Naltrexone—alcohol dependence	7.3e-05	0.000677	CcSEcCtD
Fluoxetine—Orthostatic hypotension—Citalopram—alcohol dependence	7.29e-05	0.000677	CcSEcCtD
Fluoxetine—Hypokalaemia—Citalopram—alcohol dependence	7.27e-05	0.000675	CcSEcCtD
Fluoxetine—Malaise—Acamprosate—alcohol dependence	7.24e-05	0.000672	CcSEcCtD
Fluoxetine—Breast disorder—Citalopram—alcohol dependence	7.22e-05	0.00067	CcSEcCtD
Fluoxetine—Vertigo—Acamprosate—alcohol dependence	7.21e-05	0.000669	CcSEcCtD
Fluoxetine—Syncope—Acamprosate—alcohol dependence	7.19e-05	0.000668	CcSEcCtD
Fluoxetine—Toxic epidermal necrolysis—Citalopram—alcohol dependence	7.19e-05	0.000668	CcSEcCtD
Fluoxetine—Leukopenia—Acamprosate—alcohol dependence	7.18e-05	0.000667	CcSEcCtD
Fluoxetine—ABCB1—blood—alcohol dependence	7.14e-05	0.00256	CbGeAlD
Fluoxetine—Tremor—Naltrexone—alcohol dependence	7.11e-05	0.00066	CcSEcCtD
Fluoxetine—Palpitations—Acamprosate—alcohol dependence	7.09e-05	0.000658	CcSEcCtD
Fluoxetine—Gastritis—Citalopram—alcohol dependence	7.07e-05	0.000656	CcSEcCtD
Fluoxetine—Loss of consciousness—Acamprosate—alcohol dependence	7.05e-05	0.000655	CcSEcCtD
Fluoxetine—ABCB1—midbrain—alcohol dependence	7.05e-05	0.00253	CbGeAlD
Fluoxetine—Alanine aminotransferase increased—Citalopram—alcohol dependence	7.04e-05	0.000654	CcSEcCtD
Fluoxetine—Muscular weakness—Citalopram—alcohol dependence	7.04e-05	0.000654	CcSEcCtD
Fluoxetine—Ill-defined disorder—Naltrexone—alcohol dependence	7.04e-05	0.000654	CcSEcCtD
Fluoxetine—Cough—Acamprosate—alcohol dependence	7e-05	0.00065	CcSEcCtD
Fluoxetine—Agitation—Naltrexone—alcohol dependence	6.98e-05	0.000648	CcSEcCtD
Fluoxetine—Convulsion—Acamprosate—alcohol dependence	6.95e-05	0.000645	CcSEcCtD
Fluoxetine—Abdominal distension—Citalopram—alcohol dependence	6.95e-05	0.000645	CcSEcCtD
Fluoxetine—Angioedema—Naltrexone—alcohol dependence	6.94e-05	0.000644	CcSEcCtD
Fluoxetine—Hypertension—Acamprosate—alcohol dependence	6.93e-05	0.000643	CcSEcCtD
Fluoxetine—Dysphagia—Citalopram—alcohol dependence	6.9e-05	0.000641	CcSEcCtD
Fluoxetine—Asthma—Citalopram—alcohol dependence	6.9e-05	0.000641	CcSEcCtD
Fluoxetine—Influenza—Citalopram—alcohol dependence	6.9e-05	0.000641	CcSEcCtD
Fluoxetine—Malaise—Naltrexone—alcohol dependence	6.85e-05	0.000635	CcSEcCtD
Fluoxetine—Eosinophilia—Citalopram—alcohol dependence	6.83e-05	0.000634	CcSEcCtD
Fluoxetine—Myalgia—Acamprosate—alcohol dependence	6.83e-05	0.000634	CcSEcCtD
Fluoxetine—Chest pain—Acamprosate—alcohol dependence	6.83e-05	0.000634	CcSEcCtD
Fluoxetine—Arthralgia—Acamprosate—alcohol dependence	6.83e-05	0.000634	CcSEcCtD
Fluoxetine—Syncope—Naltrexone—alcohol dependence	6.81e-05	0.000632	CcSEcCtD
Fluoxetine—Anxiety—Acamprosate—alcohol dependence	6.81e-05	0.000632	CcSEcCtD
Fluoxetine—Bronchospasm—Citalopram—alcohol dependence	6.79e-05	0.00063	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	6.78e-05	0.00063	CcSEcCtD
Fluoxetine—Pancreatitis—Citalopram—alcohol dependence	6.77e-05	0.000628	CcSEcCtD
Fluoxetine—HTR2A—brain—alcohol dependence	6.76e-05	0.00242	CbGeAlD
Fluoxetine—Discomfort—Acamprosate—alcohol dependence	6.75e-05	0.000626	CcSEcCtD
Fluoxetine—Angina pectoris—Citalopram—alcohol dependence	6.72e-05	0.000624	CcSEcCtD
Fluoxetine—Sweating increased—Citalopram—alcohol dependence	6.72e-05	0.000624	CcSEcCtD
Fluoxetine—Palpitations—Naltrexone—alcohol dependence	6.71e-05	0.000623	CcSEcCtD
Fluoxetine—Dry mouth—Acamprosate—alcohol dependence	6.68e-05	0.00062	CcSEcCtD
Fluoxetine—Loss of consciousness—Naltrexone—alcohol dependence	6.67e-05	0.000619	CcSEcCtD
Fluoxetine—Bronchitis—Citalopram—alcohol dependence	6.64e-05	0.000616	CcSEcCtD
Fluoxetine—Cough—Naltrexone—alcohol dependence	6.62e-05	0.000615	CcSEcCtD
Fluoxetine—Confusional state—Acamprosate—alcohol dependence	6.6e-05	0.000613	CcSEcCtD
Fluoxetine—Convulsion—Naltrexone—alcohol dependence	6.58e-05	0.000611	CcSEcCtD
Fluoxetine—Pancytopenia—Citalopram—alcohol dependence	6.56e-05	0.000609	CcSEcCtD
Fluoxetine—Hypertension—Naltrexone—alcohol dependence	6.55e-05	0.000608	CcSEcCtD
Fluoxetine—Anaphylactic shock—Acamprosate—alcohol dependence	6.55e-05	0.000608	CcSEcCtD
Fluoxetine—Infection—Acamprosate—alcohol dependence	6.51e-05	0.000604	CcSEcCtD
Fluoxetine—Chest pain—Naltrexone—alcohol dependence	6.46e-05	0.0006	CcSEcCtD
Fluoxetine—Myalgia—Naltrexone—alcohol dependence	6.46e-05	0.0006	CcSEcCtD
Fluoxetine—Arthralgia—Naltrexone—alcohol dependence	6.46e-05	0.0006	CcSEcCtD
Fluoxetine—Dysuria—Citalopram—alcohol dependence	6.45e-05	0.000599	CcSEcCtD
Fluoxetine—Shock—Acamprosate—alcohol dependence	6.44e-05	0.000598	CcSEcCtD
Fluoxetine—Anxiety—Naltrexone—alcohol dependence	6.44e-05	0.000598	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	6.42e-05	0.000596	CcSEcCtD
Fluoxetine—Upper respiratory tract infection—Citalopram—alcohol dependence	6.42e-05	0.000596	CcSEcCtD
Fluoxetine—Thrombocytopenia—Acamprosate—alcohol dependence	6.41e-05	0.000595	CcSEcCtD
Fluoxetine—Tachycardia—Acamprosate—alcohol dependence	6.39e-05	0.000593	CcSEcCtD
Fluoxetine—Discomfort—Naltrexone—alcohol dependence	6.39e-05	0.000593	CcSEcCtD
Fluoxetine—Pollakiuria—Citalopram—alcohol dependence	6.38e-05	0.000592	CcSEcCtD
Fluoxetine—Skin disorder—Acamprosate—alcohol dependence	6.36e-05	0.00059	CcSEcCtD
Fluoxetine—Erectile dysfunction—Citalopram—alcohol dependence	6.36e-05	0.00059	CcSEcCtD
Fluoxetine—Hyperhidrosis—Acamprosate—alcohol dependence	6.33e-05	0.000588	CcSEcCtD
Fluoxetine—Dry mouth—Naltrexone—alcohol dependence	6.32e-05	0.000587	CcSEcCtD
Fluoxetine—Photosensitivity reaction—Citalopram—alcohol dependence	6.3e-05	0.000585	CcSEcCtD
Fluoxetine—Weight increased—Citalopram—alcohol dependence	6.28e-05	0.000583	CcSEcCtD
Fluoxetine—Confusional state—Naltrexone—alcohol dependence	6.25e-05	0.00058	CcSEcCtD
Fluoxetine—Weight decreased—Citalopram—alcohol dependence	6.24e-05	0.00058	CcSEcCtD
Fluoxetine—Anorexia—Acamprosate—alcohol dependence	6.24e-05	0.000579	CcSEcCtD
Fluoxetine—Hyperglycaemia—Citalopram—alcohol dependence	6.23e-05	0.000578	CcSEcCtD
Fluoxetine—Anaphylactic shock—Naltrexone—alcohol dependence	6.2e-05	0.000575	CcSEcCtD
Fluoxetine—ABCB1—endocrine gland—alcohol dependence	6.19e-05	0.00222	CbGeAlD
Fluoxetine—Pneumonia—Citalopram—alcohol dependence	6.19e-05	0.000575	CcSEcCtD
Fluoxetine—CYP2D6—brain—alcohol dependence	6.16e-05	0.00221	CbGeAlD
Fluoxetine—Infection—Naltrexone—alcohol dependence	6.15e-05	0.000571	CcSEcCtD
Fluoxetine—Depression—Citalopram—alcohol dependence	6.14e-05	0.00057	CcSEcCtD
Fluoxetine—Hypotension—Acamprosate—alcohol dependence	6.12e-05	0.000568	CcSEcCtD
Fluoxetine—Stevens-Johnson syndrome—Citalopram—alcohol dependence	6.1e-05	0.000566	CcSEcCtD
Fluoxetine—Shock—Naltrexone—alcohol dependence	6.1e-05	0.000566	CcSEcCtD
Fluoxetine—Acute coronary syndrome—Citalopram—alcohol dependence	6.07e-05	0.000563	CcSEcCtD
Fluoxetine—Tachycardia—Naltrexone—alcohol dependence	6.05e-05	0.000561	CcSEcCtD
Fluoxetine—Myocardial infarction—Citalopram—alcohol dependence	6.03e-05	0.00056	CcSEcCtD
Fluoxetine—Neuropathy peripheral—Citalopram—alcohol dependence	6.03e-05	0.00056	CcSEcCtD
Fluoxetine—Skin disorder—Naltrexone—alcohol dependence	6.02e-05	0.000559	CcSEcCtD
Fluoxetine—Stomatitis—Citalopram—alcohol dependence	6e-05	0.000557	CcSEcCtD
Fluoxetine—Jaundice—Citalopram—alcohol dependence	6e-05	0.000557	CcSEcCtD
Fluoxetine—Hyperhidrosis—Naltrexone—alcohol dependence	5.99e-05	0.000556	CcSEcCtD
Fluoxetine—Conjunctivitis—Citalopram—alcohol dependence	5.98e-05	0.000555	CcSEcCtD
Fluoxetine—Urinary tract infection—Citalopram—alcohol dependence	5.98e-05	0.000555	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Acamprosate—alcohol dependence	5.97e-05	0.000554	CcSEcCtD
Fluoxetine—Insomnia—Acamprosate—alcohol dependence	5.92e-05	0.00055	CcSEcCtD
Fluoxetine—ABCB1—testis—alcohol dependence	5.91e-05	0.00212	CbGeAlD
Fluoxetine—Anorexia—Naltrexone—alcohol dependence	5.91e-05	0.000548	CcSEcCtD
Fluoxetine—Sweating—Citalopram—alcohol dependence	5.9e-05	0.000548	CcSEcCtD
Fluoxetine—Paraesthesia—Acamprosate—alcohol dependence	5.88e-05	0.000546	CcSEcCtD
Fluoxetine—Haematuria—Citalopram—alcohol dependence	5.87e-05	0.000545	CcSEcCtD
Fluoxetine—Dyspnoea—Acamprosate—alcohol dependence	5.84e-05	0.000542	CcSEcCtD
Fluoxetine—Somnolence—Acamprosate—alcohol dependence	5.82e-05	0.00054	CcSEcCtD
Fluoxetine—Epistaxis—Citalopram—alcohol dependence	5.81e-05	0.000539	CcSEcCtD
Fluoxetine—ABCB1—nervous system—alcohol dependence	5.8e-05	0.00208	CbGeAlD
Fluoxetine—Sinusitis—Citalopram—alcohol dependence	5.77e-05	0.000536	CcSEcCtD
Fluoxetine—Dyspepsia—Acamprosate—alcohol dependence	5.76e-05	0.000535	CcSEcCtD
Fluoxetine—Decreased appetite—Acamprosate—alcohol dependence	5.69e-05	0.000528	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Acamprosate—alcohol dependence	5.65e-05	0.000525	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Naltrexone—alcohol dependence	5.64e-05	0.000524	CcSEcCtD
Fluoxetine—Bradycardia—Citalopram—alcohol dependence	5.62e-05	0.000522	CcSEcCtD
Fluoxetine—Insomnia—Naltrexone—alcohol dependence	5.6e-05	0.00052	CcSEcCtD
Fluoxetine—Pain—Acamprosate—alcohol dependence	5.6e-05	0.00052	CcSEcCtD
Fluoxetine—Constipation—Acamprosate—alcohol dependence	5.6e-05	0.00052	CcSEcCtD
Fluoxetine—ABCB1—liver—alcohol dependence	5.58e-05	0.002	CbGeAlD
Fluoxetine—ABCB1—central nervous system—alcohol dependence	5.58e-05	0.002	CbGeAlD
Fluoxetine—Paraesthesia—Naltrexone—alcohol dependence	5.56e-05	0.000516	CcSEcCtD
Fluoxetine—Haemoglobin—Citalopram—alcohol dependence	5.55e-05	0.000515	CcSEcCtD
Fluoxetine—Rhinitis—Citalopram—alcohol dependence	5.54e-05	0.000514	CcSEcCtD
Fluoxetine—Haemorrhage—Citalopram—alcohol dependence	5.53e-05	0.000513	CcSEcCtD
Fluoxetine—Hepatitis—Citalopram—alcohol dependence	5.53e-05	0.000513	CcSEcCtD
Fluoxetine—Dyspnoea—Naltrexone—alcohol dependence	5.52e-05	0.000513	CcSEcCtD
Fluoxetine—Somnolence—Naltrexone—alcohol dependence	5.51e-05	0.000511	CcSEcCtD
Fluoxetine—Hypoaesthesia—Citalopram—alcohol dependence	5.5e-05	0.00051	CcSEcCtD
Fluoxetine—Hallucination—Citalopram—alcohol dependence	5.5e-05	0.00051	CcSEcCtD
Fluoxetine—Pharyngitis—Citalopram—alcohol dependence	5.48e-05	0.000509	CcSEcCtD
Fluoxetine—ABCB1—cerebellum—alcohol dependence	5.45e-05	0.00196	CbGeAlD
Fluoxetine—Oedema peripheral—Citalopram—alcohol dependence	5.44e-05	0.000505	CcSEcCtD
Fluoxetine—Feeling abnormal—Acamprosate—alcohol dependence	5.4e-05	0.000501	CcSEcCtD
Fluoxetine—Decreased appetite—Naltrexone—alcohol dependence	5.39e-05	0.0005	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Acamprosate—alcohol dependence	5.35e-05	0.000497	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Naltrexone—alcohol dependence	5.35e-05	0.000496	CcSEcCtD
Fluoxetine—Fatigue—Naltrexone—alcohol dependence	5.34e-05	0.000496	CcSEcCtD
Fluoxetine—Visual impairment—Citalopram—alcohol dependence	5.32e-05	0.000494	CcSEcCtD
Fluoxetine—Constipation—Naltrexone—alcohol dependence	5.3e-05	0.000492	CcSEcCtD
Fluoxetine—Pain—Naltrexone—alcohol dependence	5.3e-05	0.000492	CcSEcCtD
Fluoxetine—Erythema multiforme—Citalopram—alcohol dependence	5.22e-05	0.000485	CcSEcCtD
Fluoxetine—Urticaria—Acamprosate—alcohol dependence	5.2e-05	0.000483	CcSEcCtD
Fluoxetine—Abdominal pain—Acamprosate—alcohol dependence	5.18e-05	0.00048	CcSEcCtD
Fluoxetine—Body temperature increased—Acamprosate—alcohol dependence	5.18e-05	0.00048	CcSEcCtD
Fluoxetine—Tinnitus—Citalopram—alcohol dependence	5.15e-05	0.000478	CcSEcCtD
Fluoxetine—Feeling abnormal—Naltrexone—alcohol dependence	5.11e-05	0.000474	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Naltrexone—alcohol dependence	5.07e-05	0.00047	CcSEcCtD
Fluoxetine—Chills—Citalopram—alcohol dependence	4.96e-05	0.00046	CcSEcCtD
Fluoxetine—Arrhythmia—Citalopram—alcohol dependence	4.94e-05	0.000458	CcSEcCtD
Fluoxetine—Urticaria—Naltrexone—alcohol dependence	4.92e-05	0.000457	CcSEcCtD
Fluoxetine—Abdominal pain—Naltrexone—alcohol dependence	4.9e-05	0.000455	CcSEcCtD
Fluoxetine—Body temperature increased—Naltrexone—alcohol dependence	4.9e-05	0.000455	CcSEcCtD
Fluoxetine—Alopecia—Citalopram—alcohol dependence	4.88e-05	0.000453	CcSEcCtD
Fluoxetine—Mental disorder—Citalopram—alcohol dependence	4.84e-05	0.000449	CcSEcCtD
Fluoxetine—Hypersensitivity—Acamprosate—alcohol dependence	4.82e-05	0.000448	CcSEcCtD
Fluoxetine—Malnutrition—Citalopram—alcohol dependence	4.81e-05	0.000446	CcSEcCtD
Fluoxetine—Flatulence—Citalopram—alcohol dependence	4.74e-05	0.00044	CcSEcCtD
Fluoxetine—Tension—Citalopram—alcohol dependence	4.72e-05	0.000438	CcSEcCtD
Fluoxetine—Dysgeusia—Citalopram—alcohol dependence	4.71e-05	0.000437	CcSEcCtD
Fluoxetine—Asthenia—Acamprosate—alcohol dependence	4.7e-05	0.000436	CcSEcCtD
Fluoxetine—Nervousness—Citalopram—alcohol dependence	4.67e-05	0.000434	CcSEcCtD
Fluoxetine—Back pain—Citalopram—alcohol dependence	4.65e-05	0.000432	CcSEcCtD
Fluoxetine—Pruritus—Acamprosate—alcohol dependence	4.63e-05	0.00043	CcSEcCtD
Fluoxetine—Muscle spasms—Citalopram—alcohol dependence	4.62e-05	0.000429	CcSEcCtD
Fluoxetine—Hypersensitivity—Naltrexone—alcohol dependence	4.56e-05	0.000424	CcSEcCtD
Fluoxetine—Tremor—Citalopram—alcohol dependence	4.51e-05	0.000418	CcSEcCtD
Fluoxetine—Diarrhoea—Acamprosate—alcohol dependence	4.48e-05	0.000416	CcSEcCtD
Fluoxetine—Ill-defined disorder—Citalopram—alcohol dependence	4.46e-05	0.000414	CcSEcCtD
Fluoxetine—Anaemia—Citalopram—alcohol dependence	4.45e-05	0.000413	CcSEcCtD
Fluoxetine—Asthenia—Naltrexone—alcohol dependence	4.44e-05	0.000413	CcSEcCtD
Fluoxetine—ABCB1—brain—alcohol dependence	4.43e-05	0.00159	CbGeAlD
Fluoxetine—Agitation—Citalopram—alcohol dependence	4.42e-05	0.00041	CcSEcCtD
Fluoxetine—Angioedema—Citalopram—alcohol dependence	4.39e-05	0.000408	CcSEcCtD
Fluoxetine—Pruritus—Naltrexone—alcohol dependence	4.38e-05	0.000407	CcSEcCtD
Fluoxetine—Malaise—Citalopram—alcohol dependence	4.34e-05	0.000403	CcSEcCtD
Fluoxetine—Dizziness—Acamprosate—alcohol dependence	4.33e-05	0.000402	CcSEcCtD
Fluoxetine—Vertigo—Citalopram—alcohol dependence	4.32e-05	0.000401	CcSEcCtD
Fluoxetine—Syncope—Citalopram—alcohol dependence	4.31e-05	0.0004	CcSEcCtD
Fluoxetine—Leukopenia—Citalopram—alcohol dependence	4.31e-05	0.0004	CcSEcCtD
Fluoxetine—Palpitations—Citalopram—alcohol dependence	4.25e-05	0.000395	CcSEcCtD
Fluoxetine—Diarrhoea—Naltrexone—alcohol dependence	4.24e-05	0.000393	CcSEcCtD
Fluoxetine—Loss of consciousness—Citalopram—alcohol dependence	4.23e-05	0.000392	CcSEcCtD
Fluoxetine—Cough—Citalopram—alcohol dependence	4.2e-05	0.00039	CcSEcCtD
Fluoxetine—Convulsion—Citalopram—alcohol dependence	4.17e-05	0.000387	CcSEcCtD
Fluoxetine—Vomiting—Acamprosate—alcohol dependence	4.16e-05	0.000386	CcSEcCtD
Fluoxetine—Hypertension—Citalopram—alcohol dependence	4.15e-05	0.000385	CcSEcCtD
Fluoxetine—Rash—Acamprosate—alcohol dependence	4.13e-05	0.000383	CcSEcCtD
Fluoxetine—Dermatitis—Acamprosate—alcohol dependence	4.12e-05	0.000383	CcSEcCtD
Fluoxetine—Headache—Acamprosate—alcohol dependence	4.1e-05	0.000381	CcSEcCtD
Fluoxetine—Dizziness—Naltrexone—alcohol dependence	4.1e-05	0.00038	CcSEcCtD
Fluoxetine—Arthralgia—Citalopram—alcohol dependence	4.09e-05	0.00038	CcSEcCtD
Fluoxetine—Chest pain—Citalopram—alcohol dependence	4.09e-05	0.00038	CcSEcCtD
Fluoxetine—Myalgia—Citalopram—alcohol dependence	4.09e-05	0.00038	CcSEcCtD
Fluoxetine—Anxiety—Citalopram—alcohol dependence	4.08e-05	0.000379	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	4.07e-05	0.000377	CcSEcCtD
Fluoxetine—Discomfort—Citalopram—alcohol dependence	4.05e-05	0.000376	CcSEcCtD
Fluoxetine—Dry mouth—Citalopram—alcohol dependence	4e-05	0.000372	CcSEcCtD
Fluoxetine—Confusional state—Citalopram—alcohol dependence	3.96e-05	0.000367	CcSEcCtD
Fluoxetine—Vomiting—Naltrexone—alcohol dependence	3.94e-05	0.000366	CcSEcCtD
Fluoxetine—Anaphylactic shock—Citalopram—alcohol dependence	3.93e-05	0.000364	CcSEcCtD
Fluoxetine—Rash—Naltrexone—alcohol dependence	3.91e-05	0.000363	CcSEcCtD
Fluoxetine—Dermatitis—Naltrexone—alcohol dependence	3.9e-05	0.000362	CcSEcCtD
Fluoxetine—Infection—Citalopram—alcohol dependence	3.9e-05	0.000362	CcSEcCtD
Fluoxetine—Nausea—Acamprosate—alcohol dependence	3.89e-05	0.000361	CcSEcCtD
Fluoxetine—Headache—Naltrexone—alcohol dependence	3.88e-05	0.00036	CcSEcCtD
Fluoxetine—Shock—Citalopram—alcohol dependence	3.86e-05	0.000358	CcSEcCtD
Fluoxetine—Thrombocytopenia—Citalopram—alcohol dependence	3.84e-05	0.000357	CcSEcCtD
Fluoxetine—Tachycardia—Citalopram—alcohol dependence	3.83e-05	0.000356	CcSEcCtD
Fluoxetine—Skin disorder—Citalopram—alcohol dependence	3.81e-05	0.000354	CcSEcCtD
Fluoxetine—Hyperhidrosis—Citalopram—alcohol dependence	3.79e-05	0.000352	CcSEcCtD
Fluoxetine—Anorexia—Citalopram—alcohol dependence	3.74e-05	0.000347	CcSEcCtD
Fluoxetine—Nausea—Naltrexone—alcohol dependence	3.68e-05	0.000342	CcSEcCtD
Fluoxetine—Hypotension—Citalopram—alcohol dependence	3.67e-05	0.00034	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Citalopram—alcohol dependence	3.58e-05	0.000332	CcSEcCtD
Fluoxetine—Insomnia—Citalopram—alcohol dependence	3.55e-05	0.00033	CcSEcCtD
Fluoxetine—Paraesthesia—Citalopram—alcohol dependence	3.52e-05	0.000327	CcSEcCtD
Fluoxetine—Dyspnoea—Citalopram—alcohol dependence	3.5e-05	0.000325	CcSEcCtD
Fluoxetine—Somnolence—Citalopram—alcohol dependence	3.49e-05	0.000324	CcSEcCtD
Fluoxetine—Dyspepsia—Citalopram—alcohol dependence	3.46e-05	0.000321	CcSEcCtD
Fluoxetine—Decreased appetite—Citalopram—alcohol dependence	3.41e-05	0.000317	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Citalopram—alcohol dependence	3.39e-05	0.000315	CcSEcCtD
Fluoxetine—Fatigue—Citalopram—alcohol dependence	3.38e-05	0.000314	CcSEcCtD
Fluoxetine—Pain—Citalopram—alcohol dependence	3.36e-05	0.000312	CcSEcCtD
Fluoxetine—Constipation—Citalopram—alcohol dependence	3.36e-05	0.000312	CcSEcCtD
Fluoxetine—Feeling abnormal—Citalopram—alcohol dependence	3.23e-05	0.0003	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Citalopram—alcohol dependence	3.21e-05	0.000298	CcSEcCtD
Fluoxetine—Urticaria—Citalopram—alcohol dependence	3.12e-05	0.000289	CcSEcCtD
Fluoxetine—Body temperature increased—Citalopram—alcohol dependence	3.1e-05	0.000288	CcSEcCtD
Fluoxetine—Abdominal pain—Citalopram—alcohol dependence	3.1e-05	0.000288	CcSEcCtD
Fluoxetine—Hypersensitivity—Citalopram—alcohol dependence	2.89e-05	0.000268	CcSEcCtD
Fluoxetine—Asthenia—Citalopram—alcohol dependence	2.82e-05	0.000261	CcSEcCtD
Fluoxetine—Pruritus—Citalopram—alcohol dependence	2.78e-05	0.000258	CcSEcCtD
Fluoxetine—Diarrhoea—Citalopram—alcohol dependence	2.69e-05	0.000249	CcSEcCtD
Fluoxetine—Dizziness—Citalopram—alcohol dependence	2.6e-05	0.000241	CcSEcCtD
Fluoxetine—Vomiting—Citalopram—alcohol dependence	2.5e-05	0.000232	CcSEcCtD
Fluoxetine—Rash—Citalopram—alcohol dependence	2.47e-05	0.00023	CcSEcCtD
Fluoxetine—Dermatitis—Citalopram—alcohol dependence	2.47e-05	0.00023	CcSEcCtD
Fluoxetine—Headache—Citalopram—alcohol dependence	2.46e-05	0.000228	CcSEcCtD
Fluoxetine—Nausea—Citalopram—alcohol dependence	2.33e-05	0.000216	CcSEcCtD
Fluoxetine—HTR2C—GPCR downstream signaling—OPRM1—alcohol dependence	1.71e-05	0.000418	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—CHRM2—alcohol dependence	1.69e-05	0.000414	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—PDYN—alcohol dependence	1.68e-05	0.000411	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—ADH1A—alcohol dependence	1.68e-05	0.000411	CbGpPWpGaD
Fluoxetine—ABCB1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	1.66e-05	0.000407	CbGpPWpGaD
Fluoxetine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	1.65e-05	0.000402	CbGpPWpGaD
Fluoxetine—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	1.63e-05	0.000399	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—CHRM2—alcohol dependence	1.62e-05	0.000396	CbGpPWpGaD
Fluoxetine—HTR2A—SIDS Susceptibility Pathways—EP300—alcohol dependence	1.62e-05	0.000395	CbGpPWpGaD
Fluoxetine—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	1.61e-05	0.000393	CbGpPWpGaD
Fluoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	1.61e-05	0.000393	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR ligand binding—AVP—alcohol dependence	1.6e-05	0.000391	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—NPY—alcohol dependence	1.58e-05	0.000385	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ADH6—alcohol dependence	1.57e-05	0.000383	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CRHR1—alcohol dependence	1.56e-05	0.000382	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—OPRM1—alcohol dependence	1.55e-05	0.00038	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—OPRK1—alcohol dependence	1.54e-05	0.000377	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR ligand binding—HTR2A—alcohol dependence	1.53e-05	0.000375	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—ADH6—alcohol dependence	1.53e-05	0.000374	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—HTR1B—alcohol dependence	1.52e-05	0.000371	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—CRH—alcohol dependence	1.52e-05	0.000371	CbGpPWpGaD
Fluoxetine—CYP3A4—Biological oxidations—GGT1—alcohol dependence	1.5e-05	0.000366	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—OPRM1—alcohol dependence	1.49e-05	0.000363	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CHRM2—alcohol dependence	1.47e-05	0.000359	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—ADH4—alcohol dependence	1.46e-05	0.000357	CbGpPWpGaD
Fluoxetine—CYP2C19—Biological oxidations—POMC—alcohol dependence	1.45e-05	0.000355	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—ADH1A—alcohol dependence	1.45e-05	0.000354	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ADH6—alcohol dependence	1.44e-05	0.000353	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—NPY—alcohol dependence	1.43e-05	0.00035	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ADH6—alcohol dependence	1.43e-05	0.000349	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—ADH4—alcohol dependence	1.43e-05	0.000349	CbGpPWpGaD
Fluoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	1.4e-05	0.000341	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—HTR1B—alcohol dependence	1.38e-05	0.000337	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—CRH—alcohol dependence	1.38e-05	0.000337	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—NPY—alcohol dependence	1.37e-05	0.000334	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—OPRM1—alcohol dependence	1.35e-05	0.00033	CbGpPWpGaD
Fluoxetine—CYP3A4—Biological oxidations—MAOA—alcohol dependence	1.34e-05	0.000328	CbGpPWpGaD
Fluoxetine—CYP2D6—Biological oxidations—POMC—alcohol dependence	1.34e-05	0.000327	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—DRD4—alcohol dependence	1.33e-05	0.000325	CbGpPWpGaD
Fluoxetine—CYP2C9—Biological oxidations—POMC—alcohol dependence	1.33e-05	0.000324	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—HTR1B—alcohol dependence	1.32e-05	0.000323	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—CRH—alcohol dependence	1.32e-05	0.000323	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ADH1A—alcohol dependence	1.3e-05	0.000318	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—CNR1—alcohol dependence	1.27e-05	0.00031	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—ADH1A—alcohol dependence	1.27e-05	0.00031	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—ADH7—alcohol dependence	1.24e-05	0.000304	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—NPY—alcohol dependence	1.24e-05	0.000304	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—HTR7—alcohol dependence	1.24e-05	0.000302	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—DRD2—alcohol dependence	1.24e-05	0.000302	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—ADH4—alcohol dependence	1.23e-05	0.000301	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR ligand binding—POMC—alcohol dependence	1.22e-05	0.000299	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ADH6—alcohol dependence	1.22e-05	0.000299	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—ADH7—alcohol dependence	1.22e-05	0.000297	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—DRD4—alcohol dependence	1.21e-05	0.000295	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—HTR1B—alcohol dependence	1.2e-05	0.000293	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CRH—alcohol dependence	1.2e-05	0.000293	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ADH1A—alcohol dependence	1.2e-05	0.000292	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—OPRD1—alcohol dependence	1.19e-05	0.000292	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—GGT2—alcohol dependence	1.19e-05	0.000291	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ADH1A—alcohol dependence	1.18e-05	0.00029	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—GGT2—alcohol dependence	1.17e-05	0.000285	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—DRD4—alcohol dependence	1.15e-05	0.000282	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—CNR1—alcohol dependence	1.15e-05	0.000281	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—PDYN—alcohol dependence	1.14e-05	0.00028	CbGpPWpGaD
Fluoxetine—CYP1A2—Biological oxidations—POMC—alcohol dependence	1.13e-05	0.000277	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—DRD2—alcohol dependence	1.12e-05	0.000275	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—HTR7—alcohol dependence	1.12e-05	0.000275	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ADH4—alcohol dependence	1.1e-05	0.00027	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—CNR1—alcohol dependence	1.1e-05	0.000269	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—ADH1B—alcohol dependence	1.09e-05	0.000266	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—ADH4—alcohol dependence	1.08e-05	0.000264	CbGpPWpGaD
Fluoxetine—ALB—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	1.08e-05	0.000263	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—DRD2—alcohol dependence	1.07e-05	0.000263	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—HTR7—alcohol dependence	1.07e-05	0.000263	CbGpPWpGaD
Fluoxetine—ALB—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	1.07e-05	0.00026	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—ADH1B—alcohol dependence	1.07e-05	0.00026	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—WASF2—alcohol dependence	1.06e-05	0.00026	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CRHR1—alcohol dependence	1.06e-05	0.00026	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR ligand binding—POMC—alcohol dependence	1.06e-05	0.00026	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—DRD4—alcohol dependence	1.05e-05	0.000256	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—ADH7—alcohol dependence	1.05e-05	0.000256	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—AVP—alcohol dependence	1.04e-05	0.000255	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—OPRD1—alcohol dependence	1.04e-05	0.000253	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—WASF1—alcohol dependence	1.02e-05	0.000249	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ADH4—alcohol dependence	1.02e-05	0.000248	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ADH1A—alcohol dependence	1.01e-05	0.000247	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ADH4—alcohol dependence	1.01e-05	0.000246	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—GGT2—alcohol dependence	1e-05	0.000245	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CNR1—alcohol dependence	1e-05	0.000244	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CHRM2—alcohol dependence	1e-05	0.000244	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—PDYN—alcohol dependence	9.94e-06	0.000243	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—HTR7—alcohol dependence	9.76e-06	0.000238	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—DRD2—alcohol dependence	9.76e-06	0.000238	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	9.57e-06	0.000234	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—AVP—alcohol dependence	9.46e-06	0.000231	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ADH6—alcohol dependence	9.43e-06	0.00023	CbGpPWpGaD
Fluoxetine—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	9.42e-06	0.00023	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ADH7—alcohol dependence	9.39e-06	0.00023	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—WASF2—alcohol dependence	9.24e-06	0.000226	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CRHR1—alcohol dependence	9.24e-06	0.000226	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—OPRM1—alcohol dependence	9.18e-06	0.000224	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—ADH1B—alcohol dependence	9.18e-06	0.000224	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—ADH7—alcohol dependence	9.17e-06	0.000224	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—AVP—alcohol dependence	9.04e-06	0.000221	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—MAOB—alcohol dependence	9.03e-06	0.000221	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—GGT2—alcohol dependence	9.01e-06	0.00022	CbGpPWpGaD
Fluoxetine—ALB—Transmembrane transport of small molecules—AVP—alcohol dependence	8.9e-06	0.000217	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—WASF1—alcohol dependence	8.86e-06	0.000216	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—MAOB—alcohol dependence	8.83e-06	0.000216	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—GGT2—alcohol dependence	8.79e-06	0.000215	CbGpPWpGaD
Fluoxetine—CYP3A4—Biological oxidations—POMC—alcohol dependence	8.74e-06	0.000214	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	8.72e-06	0.000213	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CHRM2—alcohol dependence	8.68e-06	0.000212	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—HTR2A—alcohol dependence	8.67e-06	0.000212	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	8.65e-06	0.000211	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ADH7—alcohol dependence	8.64e-06	0.000211	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ADH4—alcohol dependence	8.61e-06	0.00021	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ADH7—alcohol dependence	8.57e-06	0.000209	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—NPY—alcohol dependence	8.45e-06	0.000207	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—GGT2—alcohol dependence	8.28e-06	0.000202	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ADH1B—alcohol dependence	8.24e-06	0.000201	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—AVP—alcohol dependence	8.21e-06	0.000201	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—GGT2—alcohol dependence	8.21e-06	0.000201	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—HTR1B—alcohol dependence	8.15e-06	0.000199	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CRH—alcohol dependence	8.15e-06	0.000199	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—ADH1B—alcohol dependence	8.04e-06	0.000197	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—OPRM1—alcohol dependence	7.97e-06	0.000195	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—HTR2A—alcohol dependence	7.87e-06	0.000192	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ADH1A—alcohol dependence	7.81e-06	0.000191	CbGpPWpGaD
Fluoxetine—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	7.79e-06	0.00019	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—ALDH2—alcohol dependence	7.68e-06	0.000188	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—MAOB—alcohol dependence	7.6e-06	0.000186	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ADH1B—alcohol dependence	7.58e-06	0.000185	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ADH1B—alcohol dependence	7.51e-06	0.000184	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—ALDH2—alcohol dependence	7.51e-06	0.000183	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	7.45e-06	0.000182	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—NPY—alcohol dependence	7.34e-06	0.000179	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ADH7—alcohol dependence	7.32e-06	0.000179	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—DRD4—alcohol dependence	7.13e-06	0.000174	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—HTR1B—alcohol dependence	7.08e-06	0.000173	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CRH—alcohol dependence	7.08e-06	0.000173	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GGT2—alcohol dependence	7.02e-06	0.000172	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—POMC—alcohol dependence	6.92e-06	0.000169	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—MAOB—alcohol dependence	6.83e-06	0.000167	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CNR1—alcohol dependence	6.8e-06	0.000166	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—MAOB—alcohol dependence	6.66e-06	0.000163	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ADH4—alcohol dependence	6.64e-06	0.000162	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—DRD2—alcohol dependence	6.64e-06	0.000162	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—HTR7—alcohol dependence	6.64e-06	0.000162	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—GOT2—alcohol dependence	6.53e-06	0.00016	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—ALDH2—alcohol dependence	6.47e-06	0.000158	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ADH1B—alcohol dependence	6.42e-06	0.000157	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—GOT2—alcohol dependence	6.38e-06	0.000156	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—POMC—alcohol dependence	6.29e-06	0.000154	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—MAOB—alcohol dependence	6.28e-06	0.000153	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—MAOB—alcohol dependence	6.22e-06	0.000152	CbGpPWpGaD
Fluoxetine—ALB—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	6.22e-06	0.000152	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—DRD4—alcohol dependence	6.19e-06	0.000151	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—CYP2E1—alcohol dependence	6.14e-06	0.00015	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—POMC—alcohol dependence	6.01e-06	0.000147	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—CYP2E1—alcohol dependence	6e-06	0.000147	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CNR1—alcohol dependence	5.91e-06	0.000144	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ALDH2—alcohol dependence	5.8e-06	0.000142	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—HTR7—alcohol dependence	5.76e-06	0.000141	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—DRD2—alcohol dependence	5.76e-06	0.000141	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—ALDH2—alcohol dependence	5.66e-06	0.000138	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ADH7—alcohol dependence	5.65e-06	0.000138	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—GGT1—alcohol dependence	5.64e-06	0.000138	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—GOT1—alcohol dependence	5.64e-06	0.000138	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—AVP—alcohol dependence	5.59e-06	0.000137	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	5.58e-06	0.000136	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—GGT1—alcohol dependence	5.51e-06	0.000135	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—GOT1—alcohol dependence	5.51e-06	0.000135	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—GOT2—alcohol dependence	5.5e-06	0.000134	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—POMC—alcohol dependence	5.46e-06	0.000133	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GGT2—alcohol dependence	5.42e-06	0.000132	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ALDH2—alcohol dependence	5.34e-06	0.00013	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—MAOB—alcohol dependence	5.32e-06	0.00013	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ALDH2—alcohol dependence	5.29e-06	0.000129	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—CYP2E1—alcohol dependence	5.17e-06	0.000126	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	5.09e-06	0.000124	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—MAOA—alcohol dependence	5.05e-06	0.000123	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ADH1B—alcohol dependence	4.95e-06	0.000121	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—MAOA—alcohol dependence	4.94e-06	0.000121	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—GOT2—alcohol dependence	4.94e-06	0.000121	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—AVP—alcohol dependence	4.85e-06	0.000119	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—GOT2—alcohol dependence	4.82e-06	0.000118	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—GOT1—alcohol dependence	4.75e-06	0.000116	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—GGT1—alcohol dependence	4.75e-06	0.000116	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—HTR2A—alcohol dependence	4.65e-06	0.000114	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—CYP2E1—alcohol dependence	4.64e-06	0.000113	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—GOT2—alcohol dependence	4.54e-06	0.000111	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—EP300—alcohol dependence	4.53e-06	0.000111	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—CYP2E1—alcohol dependence	4.53e-06	0.000111	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ALDH2—alcohol dependence	4.52e-06	0.000111	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—GOT2—alcohol dependence	4.5e-06	0.00011	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	4.35e-06	0.000106	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—CYP2E1—alcohol dependence	4.27e-06	0.000104	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—GGT1—alcohol dependence	4.26e-06	0.000104	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—GOT1—alcohol dependence	4.26e-06	0.000104	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—MAOA—alcohol dependence	4.25e-06	0.000104	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—CYP2E1—alcohol dependence	4.23e-06	0.000103	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—GGT1—alcohol dependence	4.16e-06	0.000102	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—GOT1—alcohol dependence	4.16e-06	0.000102	CbGpPWpGaD
Fluoxetine—ALB—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	4.12e-06	0.000101	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—MAOB—alcohol dependence	4.1e-06	0.0001	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—GGT1—alcohol dependence	3.92e-06	9.58e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—GOT1—alcohol dependence	3.92e-06	9.58e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—GGT1—alcohol dependence	3.88e-06	9.49e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—GOT1—alcohol dependence	3.88e-06	9.49e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GOT2—alcohol dependence	3.85e-06	9.4e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—MAOA—alcohol dependence	3.82e-06	9.33e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—MAOA—alcohol dependence	3.73e-06	9.11e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—POMC—alcohol dependence	3.71e-06	9.07e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	3.7e-06	9.05e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—CYP2E1—alcohol dependence	3.62e-06	8.84e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—MAOA—alcohol dependence	3.51e-06	8.58e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ALDH2—alcohol dependence	3.49e-06	8.53e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—MAOA—alcohol dependence	3.48e-06	8.51e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	3.38e-06	8.25e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GOT1—alcohol dependence	3.32e-06	8.11e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GGT1—alcohol dependence	3.32e-06	8.11e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—POMC—alcohol dependence	3.29e-06	8.04e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—POMC—alcohol dependence	3.22e-06	7.88e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—POMC—alcohol dependence	3.21e-06	7.86e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—MAOA—alcohol dependence	2.97e-06	7.27e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GOT2—alcohol dependence	2.97e-06	7.25e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.88e-06	7.05e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CYP2E1—alcohol dependence	2.79e-06	6.82e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—POMC—alcohol dependence	2.77e-06	6.77e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GOT1—alcohol dependence	2.56e-06	6.26e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GGT1—alcohol dependence	2.56e-06	6.26e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—POMC—alcohol dependence	2.49e-06	6.07e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—EP300—alcohol dependence	2.46e-06	6.02e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—POMC—alcohol dependence	2.43e-06	5.93e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—MAOA—alcohol dependence	2.3e-06	5.61e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—POMC—alcohol dependence	2.29e-06	5.59e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—POMC—alcohol dependence	2.27e-06	5.54e-05	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—EP300—alcohol dependence	2.18e-06	5.33e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—EP300—alcohol dependence	2.14e-06	5.23e-05	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—EP300—alcohol dependence	2.13e-06	5.21e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—POMC—alcohol dependence	1.94e-06	4.73e-05	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—EP300—alcohol dependence	1.84e-06	4.49e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—EP300—alcohol dependence	1.65e-06	4.03e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—EP300—alcohol dependence	1.61e-06	3.93e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—EP300—alcohol dependence	1.52e-06	3.71e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—EP300—alcohol dependence	1.5e-06	3.67e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—POMC—alcohol dependence	1.49e-06	3.65e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—EP300—alcohol dependence	1.28e-06	3.14e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—EP300—alcohol dependence	9.91e-07	2.42e-05	CbGpPWpGaD
